<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress/2.2.1" -->
<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/">
<channel>
	<title>Comments on: Hormone therapy rates no different than &#8216;watchful waiting&#8217; in prostate cancer</title>
	<link>http://www.askmenhealth.org/blog/prostate/hormone-therapy-rates-no-different-than-watchful-waiting-in-prostate-cancer</link>
	<description>Recent news and info related to conditions and diseases that could influence men's health.</description>
	<pubDate>Thu, 20 Nov 2008 09:20:53 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.2.1</generator>

	<item>
		<title>By: Hormone therapy rates no different than ‘watchful waiting’ in prostate cancer &#183; Prostate Cancer</title>
		<link>http://www.askmenhealth.org/blog/prostate/hormone-therapy-rates-no-different-than-watchful-waiting-in-prostate-cancer#comment-3794</link>
		<author>Hormone therapy rates no different than ‘watchful waiting’ in prostate cancer &#183; Prostate Cancer</author>
		<pubDate>Thu, 10 Jul 2008 23:56:05 +0000</pubDate>
		<guid>http://www.askmenhealth.org/blog/prostate/hormone-therapy-rates-no-different-than-watchful-waiting-in-prostate-cancer#comment-3794</guid>
		<description>[...] Advanced Prostate Cancer wrote an interesting post today onHere&#8217;s a quick excerpt A lot of doctors give androgen deprivation therapy without any evidence that it’s a good thing for early-stage prostate cancer. One of the reasons we’re in such a quagmire on prostate cancer is so many doctors have practiced medicine not supporting the clinical trials but just treating it the way they think they ought to be treating it. A recent study suggests thatthis increasingly common therapy used for localized prostate cancer may not bestow any survival benefits on the patient beyond thos [...]</description>
		<content:encoded><![CDATA[<p>[&#8230;] Advanced Prostate Cancer wrote an interesting post today onHere&#8217;s a quick excerpt A lot of doctors give androgen deprivation therapy without any evidence that it’s a good thing for early-stage prostate cancer. One of the reasons we’re in such a quagmire on prostate cancer is so many doctors have practiced medicine not supporting the clinical trials but just treating it the way they think they ought to be treating it. A recent study suggests thatthis increasingly common therapy used for localized prostate cancer may not bestow any survival benefits on the patient beyond thos [&#8230;]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
